Literature DB >> 16882401

Current concepts in the pathogenesis and management of exfoliation syndrome and exfoliative glaucoma.

Anastasios G P Konstas1, Sevasti Tsironi, Robert Ritch.   

Abstract

Exfoliative glaucoma is a common, sight-threatening disease that develops as a consequence of exfoliation syndrome. There are important differences in the clinical appearance, course, and prognosis of exfoliative glaucoma versus primary open-angle glaucoma. At the clinical, biochemical, and cellular levels, exfoliative glaucoma is a distinct entity, with an intriguing mechanism of development and numerous systemic manifestations that require further elucidation. The subtlety of clinical signs results in the diagnosis of exfoliative glaucoma often being overlooked and resulting in less-than-ideal management. We provide an overview of recent studies investigating the medical, laser, and surgical therapy of exfoliative glaucoma, with a focus on innovative approaches that may slow the progression of, or even prevent, the development of exfoliation syndrome and exfoliative glaucoma.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16882401

Source DB:  PubMed          Journal:  Compr Ophthalmol Update        ISSN: 1527-7313


  3 in total

1.  Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study.

Authors:  A G P Konstas; G Holló; M Irkec; S Tsironi; I Durukan; M Goldenfeld; S Melamed
Journal:  Br J Ophthalmol       Date:  2006-11-23       Impact factor: 4.638

2.  Evaluation of MMP1 and MMP3 gene polymorphisms in exfoliation syndrome and exfoliation glaucoma.

Authors:  Evangelia E Tsironi; Maria Pefkianaki; Aspasia Tsezou; Maria G Kotoula; Efthimios Dardiotis; Pavlina Almpanidou; Afroditi A Papathanasiou; Paraskevi Rodopoulou; Dimitrios Z Chatzoulis; Georgios M Hadjigeorgiou
Journal:  Mol Vis       Date:  2009-12-25       Impact factor: 2.367

3.  Clinical spectrum of pseudoexfoliation syndrome-An electronic records audit.

Authors:  Aparna Rao; Debananda Padhy; Prity Sahay; Amiya Pradhan; Sarada Sarangi; Gopinath Das; Niranjan Raj
Journal:  PLoS One       Date:  2017-10-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.